A World Health Organization-led team investigating the origins of the COVID-19 pandemic will meet Chinese scientists on Friday and plans to visit labs, markets and hospitals in Wuhan, the WHO said. The team left its quarantine hotel in Wuhan on Thursday to begin field work, two weeks after arriving in the Chinese city where the virus emerged in late 2019. The mission has been plagued by delays, concern over access and bickering between China and the United States, which has accused China of hiding the extent of the initial outbreak and criticised the terms of the visit, under which Chinese experts conducted the first phase of research.
(3)
LONDON (dpa-AFX) - Today s Daily Dose brings you news about Applied Genetic s Achromatopsia trial results; the deadlock in AstraZeneca vaccine supply in EU; partnership of Lilly, Vir Biotech and GlaxoSmithKline in fighting COVID-19; and ZymeWork s progress with ZW49 study.
Read on.
1. Applied Genetic Throws Light on Achromatopsia Trials
Applied Genetic Technologies Corp. s (AGTC) phase I/II clinical trials evaluating AAV gene therapy product candidates in patients with achromatopsia caused by CNGB3 or CNGA3 mutations, dubbed ACHMB3 and ACHMA3 trials, have provided for the first time quantitative evidence of improvements in visual sensitivity.
Achromatopsia (ACHM) is an inherited condition caused by mutations in one of several genes, with the two most common being mutations in either the CNGB3 or CNGA3 genes.
India has attracted total FDI inflow of $58.37 billion during April to November 2020. It is the highest ever for the first eight months of a financial year (F.Y.) and 22% higher as compared to the first eight months of 2019-20 ($47.67 billion).
ISLAMABAD: A team of Wildlife Department has arrived in Tharparkar to probe mysterious death of peacocks.The residents of Kharo Bajeer and Bhakao villages in Tharparkar said at least 20 peacocks.